Finance
ROTH MKM lifts Chemomab Therapeutics Ltd ADR [CMMB] price estimate. Who else is bullish?
Chemomab Therapeutics Ltd ADR [NASDAQ: CMMB] gained 6.37% or 0.04 points to close at $0.67 with a heavy trading volume of 8936084 shares. The company report on February 20, 2024 at 7:00 AM that Chemomab Awarded New Patents for CM-101, Its First-in Class Monoclonal Antibody
